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Abstract
Background: Toll-like receptor-4 (TLR4) triggers inflammatory signaling in response to microbial lipoploysaccharide.
It has been reported that loss of TLR4 protected against saturated fat-induced inflammation and insulin resistance.
It is not known whether loss of TLR4 function offers protection against trans fat (TF) induced obesity, inflammation,
and insulin resistance. We investigated whether mice with loss of function mutation in TLR4 were resistant to TF-
induced pathologies such as obesity, inflammation, hyperglycemia, and hyperinsulinemia.
Methods: C57BL/6j and C57BL/10 mice were cross bred to generate TLR4 mutant and wild type (WT). TLR4 mutant
(n = 12) and WT (n = 12) mice were fed either low fat (LF) (13.5% fat energy) or high TF diets (60% fat energy) for
12 weeks. In vitro experiments were conducted on mouse macrophage cells (RAW 264.7 and J774A.1) to
investigate whether elaidic (trans 18:1) or oleic acid (cis 18:1) would upregulate inflammatory markers.
Results: TLR4 mutant mice were ~26.4% heavier than WT mice. In both genotypes, mice that received TF diet
were significantly heavier than those mice that received LF diet (P < 0.01). TLR4 mutant mice compared to WT
mice had significantly higher fasting blood glucose, serum insulin, insulin resistance, serum leptin, and serum
cholesterol when they received TF diet (P < 0.05). No upregulation of iNOS or COX2 in response to either elaidic or
oleic acid in macrophage cells was observed.
Conclusions: Loss of function mutation in TLR4 not only did not protect mice from TF-induced obesity,
hyperglycemia, hyperinsulinemia, and hypercholesterolemia but also exacerbated the above pathologies suggesting
that functional TLR4 is necessary in attenuating TF-induced deleterious effects. It is likely that TF induces
pathologies through pathways independent of TLR4.
Background
Recently, there has been a considerable interest on the
negative health effects of trans fat (TF) in the diet. TFs
are unsaturated fats with at least one double bond in
the trans configuration. Major dietary sources of TFs
are fried foods, bakery products containing hydroge-
nated vegetable oils and shortenings, margarines, and
butter. TFs increase the risk for cardiovascular diseases
(CVD) by raising LDL-cholesterol and lipoprotein (a),
lowering HDL-cholesterol [1], and adversely affecting
the endothelial function [2]. The increased risk of CVD
with TF intake is higher than the predicted effects of TF
on serum lipids alone suggesting an additional non-lipid
role for TF in the pathobiology of CVD [3]. Addition-
ally, epidemiological evidence suggests that increased
intake of TF increases the risk of type 2 diabetes [4-6].
The underlying mechanism through which TF influ-
ences the development of type 2 diabetes is not clearly
understood.
Toll-like receptors (TLRs) are pattern recognition
receptors that play a crucial role in mediating the host’s
innate immune response against microbial products.
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TLRs are expressed in various human tissues [7]. The
specific TLR, TLR4 has been implicated in fatty acid
induced inflammation and insulin resistance [8-11].
TLR4 is activated by lipopolysaccharide (LPS), a bacter-
ial endotoxin produced by Gram negative bacteria.
The binding of LPS with TLR4 is complex and involves
CD-14 and the adaptor proteins, MD-2 and myeloid
differentiation factor-88 (MyD88). The process recruits
interleukin-1 receptor-associated kinase (IRAK) leading to
the activation of nuclear factor kappa B (NF-B) [12,13].
This activated NF-B translocates into the nucleus and
induces the production of inflammatory cytokines [14].
Recently, several investigators have proposed that
saturated fatty acids act as agonists for TLR4. Observa-
tions from these studies suggested that the saturated
fat-induced TLR4 signaling pathway is a likely mechan-
ism linking dietary fat with inflammation and insulin
resistance associated with obesity and type-2 diabetes
[9,10,15-21]. Conversely, loss of function of TLR4 led to
the protection of saturated fat-induced insulin resistance
and diet-induced obesity in mice [8,22,23]. Given the
broad spectrum of agonists for TLR4, it is possible that
TLR4 may have much broader role than is currently
known [18].
Given the similarities between saturated fat and TF in
raising blood cholesterol and transducing the production
of inflammatory markers, we hypothesized that TF is a
potential agonist for the TLR4. Further, we hypothesize
that a loss of function mutation in TLR4 may protect
against high TF diet-induced inflammation and insulin
resistance in mice. Therefore, the objective of this cur-
rent study was to investigate whether loss of function
mutation in TLR4 protects against TF rich diet-induced
inflammation and insulin resistance in a mouse model.
Methods
Diets and Reagents
Rodent diet high in TF (Catalog #D06061202) from
Research Diets Inc (New Brunswick, NJ) and rodent reg-
ular low-fat (LF) chow (control diet) (Catalog #5001)
from Lab Diets, Inc were purchased. Nutrient composi-
tion of the LF control diet and the high TF diet are pre-
sented in Table 1. The high TF diet provided 60% of
total dietary energy from fat (34.9 g/100 g) with TF
accounting for 65.4% of the total fat content. The source
of TF was shortening. The LF diet provided 13.5%
energy from fat. The LF diet was trans fat free.
Oleic and elaidic acids were purchased from Matreya
(Pleasant Gap, PA). LPS and bovine serum albumin
(BSA) (fatty acid free and low endotoxin) purchased
from Sigma (St Louis, MO). Rabbit anti-mouse cycloox-
ygenase-2 (COX-2) was purchased from Cayman Che-
mical Co (Ann Arbor, MI). Rabbit anti-mouse inducible
nitric oxide synthase (iNOS) was purchased from
Upstate (Lake Placid, NY). Donkey anti-rabbit IgG anti-
bodies conjugated with horseradish peroxidase were
purchased from GE Health Care (Piscataway, NJ). All
other reagents were purchased from Sigma.
Cell culture
Mouse macrophage cell lines RAW 264.7 and J774A.1
cells were cultured in Dulbecco’s modified Eagle’s med-
ium containing 10% (v/v) heat-inactivated fetal bovine
serum albumin (BSA), 100 units/ml penicillin, and
100 μg/ml streptomycin at 37°C in a 5% CO2. Cells (5 ×
105) were plated in 6 well plates and cultured in the
presence of LPS (20 ng/ml), elaidic acid-BSA, or oleic
acid-BSA complexes for 24 h [17]. Supernatants and cell
lysates were stored at -80°C until analyzed.
Mice
C57BL6/j and C57BL/10 mice were purchased from
Jackson Laboratories (Bar Harbor, ME) and cross
bred to generate wild type (WT) mice and mice with
loss of function mutation in TLR4. C57BL/6j is the
most commonly used background strain for the gen-
eration of transgenic mice in research areas such as
diabetes, obesity, and immunology because this strain
is susceptible to diet-induced obesity and type-2 dia-
betes. Also, this strain breeds well, has longer life
span, and is less susceptible to tumors. C57BL/10 is a
homozygous strain for TLR4 mutation. Genotyping
was performed on all experimental mice before the
study. Genotyping of TLR4 mutant and WT mice
were confirmed with PCR. Mice were genotyped
using tail DNA extracted with Sigma RedExtract kit
from Invitrogen (Carlsbad, CA).
Animals were housed at 22°C with an automatically
controlled 12-h light and dark cycles. A total of 24 male
mice (12 WT and 12 with the loss of function mutation
in TLR4) of 4-wk old were used. Within each genotype,
6 mice received a control LF diet and 6 mice received a
high TF diet for 12 weeks. Mice had unlimited access to
diets and water. During the course of feeding, food
intakes were monitored on a daily basis. All experimen-
tal protocols involving animals were approved by the
Animal Ethical Committee at Emory University and
Georgia State University, Atlanta, GA.
Tissue harvest and liver histology
After collecting blood using the cardiac puncture pro-
cedure, liver, cecum, and epididymal fat tissues were
separated using sterile equipment and weighed. Liver
tissue was placed in 4% paraformaldehyde and
embedded in paraffin. Tissue sections of 5 μm in
thickness were stained with hematoxylin and eosin and
pictures were taken with a microscope that was fitted
with a camera.
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Measurement of biochemical parameters
At the end of the 12 week feeding period, mice were
fasted for 5 h and blood was collected from retrobulbar
intraorbital capillary plexus. Serum was generated by
centrifugation of blood using serum separator tubes
(Becton Dickinson, Franklin Lakes, NJ). Serum was
stored after insulin injection at -80°C until analyzed.
Serum cholesterol and triglycerides were quantified by
colorimetric kits from BioVision (Mountain View, CA).
Serum insulin, leptin, and adiponectin were analyzed by
ELISA kits purchased from Linco Research Inc (St.
Charles, MO). Insulin resistance was calculated from
fasting glucose and serum insulin concentrations using
homeostatic model assessment (HOMA-IR) (Fasing glu-
cose (mg/dL) × μunits/mL ÷ 450).
Western blotting
COX-2 and iNOS were measured in macrophage cell
lysates by immunobloting as previously described (17).
IL1-b and IL-6 concentrations in supernatants were
measured using ELISA (R&D Systems, Minneapolis,
MN) according to the manufacturer’s instructions.
b-Actin served as a loading control.
Data Analysis
Data were presented as mean ± SD of mean. The effect of
genotype (WT and TLR4 mutant) within the diet (LF and
TF) was assessed with a 2-way analysis of variance (geno-
type × diet). Group-wise comparisons between WT and
TLR4 mutant mice within the LF or TF diet were per-
formed with Bonferroni posttest (GraphPad Prism software,
San Diego, CA). Statistical significance was set at P < 0.05.
Results
Loss of TLR4 did not protect from high TF diet-induced
obesity
Average daily food intakes were not significantly different
between WT mice and mice with loss of function muta-
tion in TLR4 fed either LF diet (3.2 vs. 3.1 g/d/mouse) or
TF diet (2.3 vs. 2.6 g/day/mouse). Visceral fat (fat pad),
liver, and cecum morphologies of WT and TLR4 mutant
mice are displayed in Figure 1A-C. The appearance of
the liver from the TLR4 mutant mice that received TF
diets looked paler compared to those mice that received
control diet suggesting fat deposition in the liver. Upon
further histological examination, TLR4 mutant mice that
received TF had more and larger fat vesicles than WT
mice that received TF (Figure 2A and 2B).
After 12 wk of feeding, body weights were significantly
higher in mice with loss of function mutation in TLR4
compared to WT mice that received TF diet (30.2
vs. 38.2 g; P < 0.001). Body weights are presented in
Figure 3A. On average, TLR4 mutant mice were ~26.4%
heavier in comparison to WT mice. Regardless of
genotype, as expected, body weights of mice that received
the TF diet were significantly higher compared to body
weights of those mice that received LF diet (P < 0.01).
Weights of visceral fat pad followed similar patterns
(data not shown). Weights of the full-thickness cecum
were significantly lower in both genotype mice that
received TF diet (P < 0.001) (Figure 3B). Liver and spleen
weights were not significantly different between geno-
types that received either a LF diet or TF diet or between
diet types within the genotype (data not shown).
Serum insulin, blood glucose, insulin resistance, serum
adipokines, and selected inflammatory markers
Serum insulin and blood glucose concentrations were
measured after 5 h fasting. In both genotypes, mice that
received TF diet had higher blood glucose and serum
insulin concentrations compared to those that received
LF diet. Mice with loss of function mutation in TLR4
compared to WT mice had significantly higher blood
glucose (116 vs. 83 mg/dL; P < 0.01) and serum insulin
concentrations when they received either LF diet or TF
diet (Figure 4A and 4B). Insulin resistance, as measured
by HOMA-IR was significantly higher in TLR4 mutant
mice compared to WT mice when received TF diet
(11.2 vs. 1.77; P < 0.001) (Figure 4C).
In vitro studies in the mouse macrophage cell lines
RAW 264.7 and J774A1 showed that there was no
Table 1 Composition of laboratory diets










Fiber 5.1 (crude) -
Cellulose - 6.5
Fat
Sunflower oil 5.7 -
Soybean oil - 3.2
Shortenning3 - 31.7
Ash 7.0 -
Mineral mix - 1.3
Vitamin mix 0.25 1.3
Energy, kj/g 17.1 21.9




Fat, % energy 13.5 60.0
1Non-purified diet.
2Purified diet (trans fat free).
3Primex shortening containing 65.4 g of trans fat/100 g of total fat.
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upregulation of COX-2 and iNOS by TF. In addition,
these cells failed to induce and IL-1b and IL-6 in super-
natant in response to macrophages treated with either
elaidic acid or oleic acid (Figure 5A-C).
We measured serum leptin, adiponectin, serum amy-
loid A, keratinocyte-derived chemokine, and lipocalin-2
concentrations because these have a role in insulin resis-
tance, type-2 diabetes, and obesity. In both genotypes,
serum leptin concentrations were significantly higher in
mice that received TF diet compared to those that
received LF diet (P < 0.001). The mice with loss of func-
tion mutation in TLR4 had significantly higher (~82%)
serum leptin concentrations compared to WT mice
when they received TF diet (P < 0.002) (Figure 6A).
However, there was no significant difference in serum
concentrations of adiponectin, serum amyloid A, lipoca-
lin-2, and keratinocyte-derived chemokine between gen-
otypes or diet types (data not shown).
Serum lipids
Serum total cholesterol concentrations were significantly
higher in mice that received TF diet compared to those
that received LF diet in both genotypes (P < 0.0001).
These serum total cholesterol increases were ~140% and









Figure 1 Morphologies of visceral fat (A), liver (B), and cecum
(C) of WT and T4Mu mice that received LF and TF diets.
Abbreviations: LF, low fat diet (13.5% energy from fat); T4Mu, toll-
like receptor-4 loss of function mutant mice; TF, trans fat diet (60%
of energy from fat, shortening-based); WT, wild type mice.
WT-TF T4Mu-TF
A B
Figure 2 Liver histology of WT and T4Mu mice that received
TF diet. For simplicity, histology related to mice that received LF
diet is not presented as there were no differences. Abbreviations:
T4Mu, toll-like receptor-4 loss of function mutant mice; WT, wild
type mice.
A B
Figure 3 Body weights (A) and cecum weights (B) of WT and
T4Mu mice that received LF and TF diets. Significant difference
was determined with 2-way analysis of variance (genotype × diet
type) for body weights and cecum weights. Body weights and
cecum weights are significantly higher in T4Mu mice compared to
WT mice that received TF diet. Abbreviations: LF, low fat diet (13.5%
energy from fat); T4Mu, toll-like receptor-4 loss of function mutant
mice; TF, trans fat diet (60% of energy from fat, shortening-based);
WT, wild type mice.
A B
C
Figure 4 5-hour fasting blood glucose (A), serum insulin (B),
and HOMA-IR of WT and T4Mu mice that received LF and TF
diets. Significant difference was determined with 2-way analysis of
variance (genotype × diet type) for blood glucose, serum insulin,
and HOMA-IR. Fasting blood glucose, serum insulin, and HOMA-IR
are significantly higher in T4Mu mice compared to WT mice that
received TF diet. Abbreviations: HOMA-IR, Homeostatic Model
Assessment-Insulin Resistance; LF, low fat diet (13.5% energy from
fat); T4Mu, toll-like receptor-4 loss of function mutant mice; TF, trans
fat diet (60% of energy from fat, shortening-based); WT, wild type
mice.
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mutation in TLR4, respectively. Mice with loss of func-
tion mutation in TLR4 had significantly higher total
serum cholesterol compared to WT mice regardless of
the diet type they received (P < 0.01). Mice with loss of
function mutation in TLR4 had ~140% higher total
serum cholesterol when they received LF diet and had
~39% higher total serum cholesterol when they received
TF diet (Figure 6B). However, serum trigacylglycerol
concentrations were not significantly different between
either genotype or diet type (data not shown).
Discussion
Emerging research has established a connection between
low grade systemic inflammation and insulin resistance.
Insulin resistance is the primary characteristic of obesity
and is a risk factor for development of type-2 diabetes.
It has been reported that TF intake increased the pro-
duction of inflammatory markers such as C-reactive
protein (CRP), tumor necrosis factor-a (TNF-a), inter-
leukin-6 (IL-6), and E-selectin [2,5,6]. It is likely that
TFs are incorporated into plasma membranes of
endothelial cells, manocyte/macrophages, and adipocytes
which in turn transduces membrane signaling pathways
related to inflammation [6]. Although, proinflammatory
effect of diets high in TF has been established, the exact
molecular mechanism linking TF with inflammatory
markers is largely unknown. In this present study, we
investigated whether feeding TLR4 mutant mice a diet
high in TF would offer protection against TF-induced
obesity, insulin resistance, and inflammation in TLR4
mutant mice. We found that loss of function mutation in
TLR4 did not protect mice from high TF-diet-induced
obesity, hyperglycemia, hyperinsulinemia, hypercholester-
olemia, and hyperleptinemia.
What is interesting in this study is that mice with loss
of function mutation in TLR4 had gained ~26.4% more
weight, had ~39.9% higher blood glucose, had ~57.6%
higher serum insulin, had ~78% higher serum choles-
terol, and had ~82.5% higher serum leptin compared to
their counterpart WT mice when they were fed a diet
high in TF. Additionally, TLR4 mutant mice had higher
fat deposition than WT mice in the liver when they
received TF diet. These observations suggest that func-
tional TLR4 is important in protecting mice from trans
fat-induced obesity, hypercholesterolemia, hyperleptine-
mia, hyperglycemia, and hyperinsulienmia. The exact
mechanism through which the loss of function mutation
in TLR4 induces the above described pathologies is not
known. Recently, our collaborators, Vijay-Kumar et al
[24] reported that TLR5 deficient mice also developed
obesity, hyperlipidemia, and insulin resistance in
response to high fat diet and the transfer of gut micro-
biota from TLR5 deficient mice to WT-germ-free mice
conferred obesity, hyperlipidemia, and insulin resistance
(features of metabolic syndrome) to the recipients sug-
gesting that the gut microbiota mediate metabolic
derangements associated with high fat diet. Insulin resis-
tance we observed in TLR4 mutant mice in response to
TF diet is likely secondary to the increased adiposity of
the TLR4 mutant mice. Therefore, it is difficult to accu-
rately assess the effect of TLR4 (or lack of TLR4) on
insulin resistance/inflammation in a model where adip-
osity is not equal.
The possible explanations for the observed results
include increased fat absorption in TLR4 mutant mice








Figure 5 In vitro experiments on macrophage cell lines (RAW
264.7 and J774A1). No upregulation of inflammatory markers such
as IL-1b (A), IL-6 (B), COX2 (C), or iNOS (C) was observed in
macrophages in response to treatment with either elaidic acid or
oleic acid at 50 μM and 100 μM concentration level. b-actin was
used as a loading control. Abbreviations: COX2, cyclooxygenase 2;
iNOS, inducible nitric oxide synthase.
A B
Figure 6 5-hour fasting serum leptin (A) and serum cholesterol
(B) concentrations of WT and T4Mu mice that received LF and
TF diets. Significant difference was determined with 2-way analysis
of variance (genotype × diet type) for serum leptin and serum
cholesterol. Serum leptin and cholesterol are significantly higher in
T4Mu mice compared to WT mice that received TF diet. Serum
cholesterol is significantly higher in T4Mu mice compared to WT
mice that received LF diet. Abbreviations: LF, low fat diet (13.5%
energy from fat); T4Mu, toll-like receptor-4 loss of function mutant
mice; TF, trans fat diet (60% of energy from fat, shortening-based);
WT, wild type mice.
Vijay-Kumar et al. Journal of Inflammation 2011, 8:2
http://www.journal-inflammation.com/content/8/1/2
Page 5 of 7
in WT mice compared to TLR4 mutant mice may be
responsible for the observed pathologies. Also, it is likely
that the diet high in TF may have altered the microflora
in cecum which in turn may have altered the intestinal
barrier allowing translocation of microbial products
leading to the activation of TLR4 independent pathways
associated with inflammation, dyslipidemia, hyperinsuli-
nemia, insulin resistance, and hyperleptinemia. These
pathologies were further exacerbated in the presence of
loss of function TLR4 mutation.
To our knowledge, this is the first study that investi-
gated the effects of diet high in TF on obesity and circu-
lating glucose, insulin, leptin, and inflammatory markers
in mice with loss of function mutation in TLR4. It has
been well established that activation of TLR4 by micro-
bial endotoxin, LPS (TLR4 agonist), triggers the host’s
innate immune and inflammatory responses leading to
the upregulation of pathways relating to insulin resis-
tance and dyslipidemia. One possible mechanism is that
LPS stimulates the TLR4 and ERK1/2 signaling which in
turn activates hormone sensitive lipase and adipocyte
triglyceride lipase. This in turn increases lipolysis in adi-
pocytes leading to free fatty acid (FFA) efflux from adi-
pocytes into the blood [25]. These elevated FFAs
interfere with insulin function (unable to suppress hepa-
tic glucose production and stimulate glucose influx into
muscle and adipocytes) leading to insulin resistance
[26-29]. Shi et al [9] reported that FFAs are themselves
capable of triggering TLR4 signaling by trasducing pro-
duction of proinflammatory markers in macrophages,
adipocytes, and liver leading to insulin resistance. Insu-
lin resistance is a main pathological abnormality asso-
ciated with metabolic syndrome, obesity, and type-2
diabetes. Conversely, loss of function mutation in TLR4
protected against diet-induced obesity, hyperinsulinemia
and inflammation in response to diet high in saturated
fat [23]. Several other investigators proposed that satu-
rated fatty acids act as agonist for TLR4 and therefore
linking dietary fat with innate immune system and
inflammation [15-21,30,31]. However, our findings in
this model are at odds with the linkage of TLR4 and
diet-induced obesity, hyperinsulinemia, and inflamma-
tion in response to diet high in saturated fat [23].
Although, we did not observe the blunting of TF diet-
induced weight gain, hyperinsulinemina, and hyperglyce-
mia in mice with loss of function mutation in TLR4,
our results in this study do not directly contradict the
previously proposed connection between saturated fatty
acids and upregulation of TRL4 down-stream signaling
leading to insulin resistance and inflammation. Well
controlled studies by several investigators [23,32] offered
strong evidence that saturated fat diet-induced insulin
resistance was blunted in mice that lacked functional
TLR4. It is likely that saturated fat and trans fat induce
inflammation and insulin resistance by all together dif-
ferent mechanisms.
Conclusions
Our findings suggest that diets high in TF induce obe-
sity, hyperglycemia, insulin resistance, hypercholesterole-
mia, and hyperleptinemia even in the absence of
functional TLR4. Additionally, these pathologies asso-
ciated with TF diet were exacerbated in the presence of
loss of function mutation in TLR4. Furthermore, our
results indicate that TLR4 independent pathways may
be involved in TF-diet-induced obesity, hyperglycemia,
hyperinsulinemia, and hyperleptinemia. Further studies
are needed to decipher the complex biomolecular
mechanism linking consumption of diets rich in TF
with pathologies associated with TLR4 signaling such as
insulin resistance, metabolic syndrome, and type-2
diabetes.
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